Clinical Trial Update: B7-H3.CD28Z.CART in CNS Neoplasms [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating B7-H3.CD28Z.CART for central nervous system neoplasms is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Brain Tumor
• Central Nervous System Neoplasms
• Embryonal Tumor with Multilayered Rosettes
• Ependymoma
• Leptomeningeal Disease
• Medulloblastoma
• Pineoblastoma

Drugs mentioned

• B7-H3.CD28Z.CART

Snippet

Sponsor: Robbie Majzner | Conditions: Central Nervous System Neoplasms, Brain Tumor | Phase 1 | Status: NOT_YET_RECRUITING